BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33206331)

  • 1. The diagnostic value of miR-21 combined with CT in patients with liver cancer.
    Feng YS; Zhou JM; Sun CH; Zhu J; Yang J; Guo L
    Clin Transl Oncol; 2021 Jun; 23(6):1238-1244. PubMed ID: 33206331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
    Xu R; Wang J; Huang X; Zhang Q; Xie Y; Pang L; Bai L; Zhou J
    J BUON; 2019; 24(4):1429-1434. PubMed ID: 31646787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer.
    Kong Y; Jing Y; Sun H; Zhou S
    J Healthc Eng; 2022; 2022():5074571. PubMed ID: 35237392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
    Tian Z; Yu T; Wei H; Ning N
    J Clin Lab Anal; 2020 Feb; 34(2):e23071. PubMed ID: 31693242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
    D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
    Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT combined with tumor markers in the diagnosis and prognosis of hepatocellular carcinoma.
    Huang X; Li J; Wang F; Hao M
    J BUON; 2018; 23(4):985-991. PubMed ID: 30358203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
    Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
    Jia GS; Feng GL; Li JP; Xu HL; Wang H; Cheng YP; Yan LL; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):303-309. PubMed ID: 28603099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
    Hu RZ; Zhao SQ; Shen B; Guo GB
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):634-637. PubMed ID: 31594082
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.
    Sun XL; Yao H; Men Q; Hou KZ; Chen Z; Xu CQ; Liang LW
    World J Gastroenterol; 2017 Aug; 23(30):5602-5609. PubMed ID: 28852319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.